(Q36537367)

English

MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1).

scientific article published on 3 February 2016

Statements

MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1). (English)
Lin Zhao
Yan Wang
Longyang Jiang
Miao He
Xuefeng Bai
Lifeng Yu
Minjie Wei
3 February 2016

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit